OrthoPediatrics (NASDAQ:KIDS) Director Sells $103,000.00 in Stock

August 27, 2026 by InsiderTrades.com

Key Points

Director David Pelizzon sold 16,300 OrthoPediatrics shares for approximately $403,262 at an average price of $24.74, reducing his ownership by 0.24% while retaining more than 6.88 million shares.
OrthoPediatrics reported quarterly revenue of $70.51 million and an adjusted loss of $0.26 per share, beating analyst expectations. The stock opened at $24.03, near its 52-week high of $26.74.
The company completed the full U.S. commercial launch of its 3P Pediatric Plating Platform Hip System after more than 350 successful implantations. Analysts maintain a generally favorable outlook, with a consensus “Moderate Buy” rating and an average price target of $26.44.

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) Director David Pelizzon sold 4,000 shares of the company's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $25.75, for a total value of $103,000.00. Following the completion of the transaction, the director directly owned 6,897,764 shares of the company's stock, valued at approximately $177,617,423. This trade represents a 0.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

OrthoPediatrics Stock Down 1.9%

Shares of KIDS opened at $24.03 on Thursday. The business's 50 day moving average is $21.23 and its 200 day moving average is $18.58. The company has a market capitalization of $627.42 million, a PE ratio of -14.30 and a beta of 0.98. OrthoPediatrics Corp. has a 12-month low of $14.42 and a 12-month high of $26.74. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million during the quarter, compared to the consensus estimate of $68.21 million. Research analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Piper Sandler restated an "overweight" rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. TD Cowen reiterated a "buy" rating on shares of OrthoPediatrics in a report on Monday, June 15th. Weiss Ratings upgraded shares of OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 5th. Needham & Company LLC increased their price objective on shares of OrthoPediatrics from $30.00 to $35.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Finally, BTIG Research raised their price objective on OrthoPediatrics from $24.00 to $29.00 and gave the company a "buy" rating in a research report on Thursday, August 20th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $26.44.

View Our Latest Analysis on OrthoPediatrics

Institutional Investors Weigh In On OrthoPediatrics

Several large investors have recently added to or reduced their stakes in KIDS. BlackRock Inc. bought a new stake in shares of OrthoPediatrics in the 2nd quarter valued at approximately $24,347,000. Millennium Management LLC increased its position in shares of OrthoPediatrics by 48.0% during the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company's stock valued at $24,802,000 after purchasing an additional 452,840 shares during the last quarter. AIGH Capital Management LLC bought a new position in shares of OrthoPediatrics during the 2nd quarter valued at approximately $5,161,000. Nantahala Capital Management LLC purchased a new stake in OrthoPediatrics during the 2nd quarter valued at $4,636,002,000. Finally, AWM Investment Company Inc. purchased a new stake in OrthoPediatrics during the 2nd quarter valued at $4,537,000. 69.05% of the stock is owned by institutional investors.

More OrthoPediatrics News

Here are the key news stories impacting OrthoPediatrics this week:

Positive Sentiment: OrthoPediatrics completed the full U.S. commercial launch of its 3P™ Pediatric Plating Platform® Hip System after more than 350 successful implantations during a limited release. The company said the system addresses pediatric hip trauma and deformities, improves fixation and surgical workflow, and is the first of several planned systems in a broader plating portfolio. The launch provides a potential long-term revenue and market-share opportunity, although the company did not provide specific financial guidance. OrthoPediatrics Announces Full Commercial Launch of 3P Pediatric Plating Platform Hip System
Neutral Sentiment: Reported short interest was listed as zero shares with a zero-day short-interest ratio. However, the filing data also showed an invalid “NaN” change, making the statistic unreliable and providing little usable insight into potential short-selling pressure.
Negative Sentiment: Director David R. Pelizzon and major shareholder entities associated with Squadron Capital and Jennifer N. Pritzker reported sales totaling 38,300 shares for approximately $943,302 across August 24–26, at prices ranging from $24.28 to $25.75. The transactions reduced the reported position by only about 0.56%, leaving ownership of roughly 6.86 million shares, so the sales appear relatively small compared with the remaining stake. Nevertheless, repeated insider selling can weigh on sentiment, particularly with KIDS trading near its 52-week high. SEC insider transaction filing

OrthoPediatrics Company Profile

(Get Free Report)

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.